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Cancer mortality in the first degree relatives of young breast cancer
patients
K.E. Anderson', D.F. Easton2, F.E. Matthews2 & J. Peto2
'Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota; 2Section of Epidemiology,
Institute of Cancer Research, Sutton, Surrey.
Summary In a retrospective cohort study, the mothers and sisters of 740 breast cancer patients aged under 36
at diagnosis have been studied for mortality and cancer incidence. Significantly increased breast cancer
mortality was observed below age 60 (30 deaths; SMR = 3.4), but not at older ages (four deaths; SMR = 0.9).
The cumulative breast cancer incidence in the relatives was 3.6% by age 50, 7.6% by age 60 and 11.6% by age
70. They also suffered excess mortality below age 60 for cancers of reproductive sites (cervix, ovary and
endometrium; 15 deaths; SMR = 2.6) and lung (11 deaths; SMR = 3.2), but not for other sites (12 deaths;
SMR = 0.9). This large population-based cohort study provides further confirmation of genetic susceptibility
to breast cancer at young ages.
A family history of breast cancer in a close relative is a well
known risk factor for the disease (Kelsey & Gammon, 1990).
Various studies have shown that the risk in first degree
relatives is greatest for those with a family history of breast
cancer with an early age of onset (Ottman et al., 1986; Claus
et al., 1990). Most such studies are, however, based to some
extent on family history as reported by the index case,
although cases may have been confirmed by hospital records
or death certificates in some studies. Unbiased data on the
magnitude of the risk, and on its dependence on age at onset
of the index case and her relatives, are needed both for
genetic counselling and to elucidate the underlying mechan-
isms of breast cancer.
In this study, 740 index cases were identified in a popu-
lation-based case-control study of breast cancer and oral
contraceptive use (UK National Case-Control Study Group,
1989). Details provided by the cases were used to trace their
mothers and sisters through the National Health Service
Central Register (NHSCR) for mortality and cancer inci-
dence. This tracing procedure provides almost unbiased esti-
mates of mortality and cancer incidence among relatives
compared with national rates, and also establishes a prospec-
tive cohort for future analysis.
Methods
Case selection and interviewing
The methods of case ascertainment and data collection have
been fully described elsewhere (UK National Case-Control
Study Group, 1989). All known cases of breast cancer in
women aged under 36 diagnosed between January 1, 1982
and December 31, 1985 who were resident in 11 regional
health authority areas in Britain were ascertained. Cases were
identified primarily through local cancer registries, with addi-
tional information from hospital discharge and computerised
patient lists at major treatment centres. The study was
restricted to white women diagnosed in Britain with no
previous malignancy, severe mental handicap or psychiatric
condition. All diagnoses were confirmed by pathology report.
After obtaining permission from the responsible clinician, the
cases were contacted by letter and subsequent telephone call,
and were invited to participate in a 'study of women's
health'. Cases who initially refused were contacted again 6
months later. Of the total of 1049 cases diagnosed in the
study area and period, 16% had died prior to contact, and
the clinician refused permission to contact a further 7%. The
overall response rate among the remaining 811 cases was
90%. Women who agreed to take part were visited by
trained interviewers in their homes.
Family tracing
During the routine face to face interview, the cases were
asked to provide full names and dates of birth of their
mother and any sisters. Only full sisters and natural mothers
were included in the cohort.
The mothers and sisters were traced through the NHSCR
to obtain details of deaths and cancer registrations. The
Department of Health and Social Security Register was also
used to trace individuals whose records were not found in the
NHSCR. Follow-up for the entire cohort is complete to the
end of 1989. Deaths were coded according to the ninth
revision of the International Classification of Diseases (ICD).
Statistical methods
As incident cancers were not recorded in the NHSCR before
1971 and registration is not complete thereafter, relative risk
estimates are based only on the mortality data. Woman-years
at risk were calculated using the 'Person-Years' program,
(Coleman et al., 1989). Follow-up began on their 10th birth-
day for sisters, and on the date of birth of the case for
mothers. Deaths and woman-years after age 85 were ignored.
Follow-up closed on December 31, 1989. Expected numbers
of deaths were computed using age-, sex- and calendar
period-specific mortality rates for England and Wales. Two-
sided 95% confidence intervals for relative risk estimates are
based on the Poisson distribution (Breslow & Day, 1987).
Results
Follow-up
Of the 755 cases in the original study we excluded 14 who
were adopted, and one whose sister was also a case. (To
avoid double counting only the elder sister was included.)
The follow up status of the relatives of the remaining 740
cases is shown in Table 1. Of the 1568 first degree female
relatives, 2% (28) had emigrated and 9% (148) were either
untraced or had never lived in Britain. One hundred and fifty
four had died before the end of 1989, and 1238 were alive.
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Table I Status of cohort members at the end of 1989
Lost to
Relative Alive Dead Emigrated follow-up' Total
Mothers 511 142 4 83 740
Sisters 727 12 24 65 828
Total 1238 154 28 148 1568
aIncluding relatives of index cases who refused to provide adequate
identifying information.
Breast cancers
Table II gives details of the breast cancer cases in relatives
identified by this study. Seventy one cases (9.4%) reported a
family history of breast cancer in the original study. One
further case has subsequently been identified, and two repor-
ted cases are excluded - one where the affected relative was a
half sister, and one (noted above) whose elder sister was also
a case. Of the remaining 70 reported breast cancers, 32
(46%) were notified as dead by the NHSCR and confirmed
by death certificate. (In two of these cases, breast cancer was
not the underlying certified cause of death.) A further 17 of
these cases were notified as breast cancer registrations. Of
those not confirmed, nine occurred in individuals whose
records could not be traced, and one occurred before 1971,
when national tracing of registered cancers began, leaving 11
in whom national records provided no indication of breast
cancer. Six further breast cancers (including four deaths), not
reported by the case, were identified by tracing, so that a
total of 76 breast cancers were identified from all sources. All
the 36 breast cancer deaths occurred in mothers. Five reg-
istered cancers occurred in sisters and a further three were
reported by the case.
Overall mortality
Table III shows mortality in mothers and sisters for specific
causes of death. There was no marked overall excess mor-
tality from cancers other than breast cancer (51 deaths,
SMR 1.26, P = 0.13), although there was stronger evidence
of an excess below age 50 (20 deaths, SMR 2.01, P = .007).
Cancers of the cervix, endometrium and lung were all
significantly elevated below age 50 (SMRs 3.47, 10.53 and
5.88 respectively), although cervix and lung were the only
sites showing a conventionally significant (P <0.05) overall
excess. There was an overall excess of ovarian cancer (SMR
1.83) which, though not significant, is consistent with other
studies which suggest a breast-ovarian cancer association in
some families (Schildkraut et al., 1989). Mortality from non-
malignant causes of death is somewhat less than expected
below age 50 (12 deaths, SMR 0.53, P=.02), but not at
older ages (57 deaths, SMR 0.90).
Early death bias, and reliability of reported incidence
These results probably reflect a slight bias in the mortality
results at young ages which is peculiar to this study design. A
case who was a child when her mother died is less likely to
recall her mother's personal details correctly, and such
mothers are therefore less likely to be traced in the NHSCR.
Twelve of the 168 untraced relatives died before aged 50. We
analysed mortality in all 168 untraced relatives using follow-
up to their 50th birthday or to their reported date of death.
Based on the cause of death reported by the index case, the
observed/expected mortality results below age 50 were: breast
cancer 2/0.42 (SMR 4.76); other cancers 3/1.01 (SMR 2.97);
other causes 7/2.32 (SMR 3.02).
Inclusion of untraced cases would thus reduce the marked
Table II Breast cancer cases in relatives
Status reported by relative
Breast cancer, alive No breast
Breast cancer, dead < 1971 1971 + cancer
Status by tracing Ma S M S M S M S
Dead, breast cancer on death certificate as:
Underlying cause 28 0 1 0 1 0 4 0
Mentioned cause 2 0 0 0 0 0 0 0
Breast cancer registration
Dead other cause 1 0 0 0 0 0 0 0
Alive 0 0 0 0 12 4 1 1
Dead, no breast cancer 1 0 0 0 1 0 103 12
Alive and traced 1 0 1 0 6 2 490 720
Emigrated 0 0 0 0 0 0 4 24
No trace 5 0 0 0 3 1 75 64
Total 38 0 2 0 23 7 677 821
aM = mother, S = sister.
Table III Mortality from specific causes by age at death
Age of relative at death
<50 50-59 60 + Total
Obs Exp OIE Obs Exp OIE Obs Exp OIE Obs Exp OIE
Cancer
Breast 15 4.17 3.59c 15 4.73 3.17c 4 4.50 0.89 34 13.40 2.54c
Stomach 1 0.53 1.89 0 0.67 - 1 1.21 0.83 2 2.41 0.83
Colorectal 0 1.08 - 1 1.70 0.59 3 2.80 1.07 4 5.58 0.72
Lung 6 1.02 5.88c 5 2.43 2.05 3 4.34 0.69 14 7.79 1.80a
Ovary 2 1.22 1.64 4 1.60 2.50 2 1.56 1.28 8 4.38 1.83
Cervix 5 1.44 3.47a 2 0.95 2.11 1 0.72 1.39 8 3.11 2.57a
Endometrium 2 0.19 10.53a 0 0.36 - 0 0.46 - 2 1.01 1.98
Other cancers 4 4.48 0.89 6 4.36 1.38 3 7.43 0.41 13 16.27 0.80
All cancers 20 9.96 2.01b 18 12.07 1.49 13 18.52 0.70 51 40.55 1.26
except breast
Non-cancer
Circulatory 5 7.45 0.67 10 11.11 0.90 27 30.16 0.90 42 48.72 0.86
Respiratory 2 2.70 0.74 2 2.50 0.80 5 5.58 0.90 9 10.78 0.84
Other 5 12.69 0.39 5 5.32 0.94 8 8.67 0.92 18 26.69 0.67
Total 47 36.97 1.27 50 35.74 1.40a 57 67.43 0.85 154 140.15 1.10
ap<.o5; bp<.Ol; cp<.001.
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deficit in non-cancer mortality below age 50 (19 deaths, SMR
0.76, P = 0.26) but would not substantially alter the results
for breast cancer below age 50 (15 deaths, SMR 3.59 exclu-
ding untraced cases; 17 deaths, SMR 3.70 including untraced
cases). Two of the other three cancer deaths below age 50 in
untraced relatives were reported as due to cervical or endo-
metrial cancer (the reported sites were one cervix, one 'womb
or cervix' and one brain) further inflating the marked com-
bined excess of these sites below age 50 shown in Table III.
As inclusion of untraced cases has only a trivial effect on the
results for breast cancer, further mortality analyses were
restricted to the traced cohort, for whom full information on
dates of birth and death, and certified cause of death is
available. For the purpose of calculating incidence rates how-
ever, we included untraced cases. Moreover, for the reasons
outlined in the discussion, cases and deaths reported from
any source were included in the incidence analyses.
Breast cancer mortality
Breast cancer mortality in the first degree relatives of index
cases, subdivided by age of relative, is shown in Table IV.
The overall SMR below age 60 is 3.4 (30 deaths, 8.90
expected) whereas above age 60 the SMR is significantly
lower, and there is no evidence of any excess (four deaths,
4.50 expected). There is however no evidence in these data of
a trend in risk with age below age 60.
Table IV Breast cancer mortality in first degree relatives of breast
cancer cases, by age of relative at death
Age of
relative at
death Obs Exp Obs/Exp (95% CI)
<40 3 1.11 2.70 (0.56, 7.90)
40-49 12 3.06 3.92 (2.03, 6.85)
50-59 15 4.73 3.17 (1.77, 5.23)
60+ 4 4.50 0.89 (0.24, 2.28)
Total 34 13.40 2.54 (1.76, 3.55)
U)
E
30 40 50 60 70
Age
Absolute breast cancer risk
The information of most direct importance for counselling
purposes is the absolute risk of breast cancer by different
ages, and we estimated this in two ways. We first constructed
a lifetable from the incidence data. For the reasons outlined
in the discussion, we included breast cancers identified from
all sources (dead, registered or reported by the case). For the
reasons discussed above we included both traced and un-
traced relatives. The estimated risks obtained by this method
were 3.6% (95% confidence interval 2.3%-4.8%) by age 50
and 11.6% (95% confidence limits 8.8%-14.3%) by age 70.
(The corresponding estimates excluding untraced individuals,
3.4% and 11.7% respectively, are almost identical). The com-
parable risks based on national registration rates for England
and Wales would be 1.5% and 4.7% respectively (these were
calculated using 1981 rates, but 1971 rates would give almost
identical figures). The full lifetable is given in Table V, and
illustrated in Figure 1. We also obtained indirect estimates of
cumulative risks to relatives by multiplying national
incidence rates by the familial relative risks based on mor-
tality. As an approximate adjustment for the effect of sur-
vival, the relative risks based on mortality were assumed to
apply to incidence rates 5 years earlier. This method gave
cumulative risks of 5.5% by age 50 and 13.2% by age 70,
slightly higher than the first method.
Figure 1 Cumulative risk of breast cancer in relatives of breast
cancer patients (continuous line) and approximate risk in the
general population based on 1981 incidence rates for England
and Wales (dashed line).
Discussion
The results of this study show an increase in breast cancer
mortality in women with a history of early-onset breast
cancer in a first degree relative as compared to the general
population. The increased risk is statistically significant and
the relative risk appears to decrease with increasing age of
the relative at risk. There is no evidence of an increasing
trend in relative risk with reducing age below age 60, as
would be expected from the results of other studies. How-
ever, the data are clearly consistent with such a trend (for
example, the upper 95% confidence limit for the relative risk
below age 40 is 7.9).
The estimates of risk in first degree relatives of young
breast cancer patients obtained in this study are comparable
with those reported by others. This is, however, one of the
largest studies of familial risks of breast cancer involving
such very young cases. Moreover, apart from one Icelandic
study (Tulinius et al., 1982), it is the first study in which all
Table V Cumulative risks of breast cancer by age in mothers and sisters of index cases
Mothers Sisters
Deaths Woman Incident Deaths Woman Incident Cumulative
Age Obs Exp years cases Obs Exp years cases risk %
< 30 0 0.02 2442.56 0 0 0.07 14860.68 0 0
30-34 0 0.15 2785.59 0 0 0.19 2969.99 1 0.09
35-39 3 0.46 3325.35 3 0 0.31 1991.98 3 0.65
40-44 7 1.04 3510.99 10 0 0.32 1072.59 3 2.05
45-49 7 1.79 3462.29 11 0 0.21 410.05 1 3.55
50-54 12 2.42 3302.37 17 0 0.10 135.68 0 5.91
55-59 5 2.67 2927.01 11 0 0.03 28.33 0 7.64
60-64 2 2.36 2216.12 7 0 0.01 5.53 0 9.09
65-69 1 1.52 1247.87 7 0 0.00 0.00 0 11.60
70-74 2 0.70 498.63 1 0 0.00 0.00 0 13.36
75-79 0 0.25 150.63 0 0 0.00 0.00 0 13.36
80-84 0 0.05 21.60 0 0 0.00 0.00 0 13.36
--_o
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family members have been traced through national records.
In this way the potential biases inherent in using reported
family history of cancer in case-control studies have been
largely avoided. In addition, we have established a prospec-
tive cohort in which details on future deaths and cancer
registrations will be routinely received.
Table II reveals a number of inconsistencies between
family history as reported by the case and that recorded in
national records. The cases did not report four (12%) of the
34 breast cancer deaths and two (11%) of the 19 registra-
tions, one of which was diagnosed after the case had been
interviewed. Conversely 12 of the 70 breast cancers reported
by the index cases (17%) were not identified by tracing, and
ten of these were either deaths or occurred since 1971 when
national cancer registration was operational. These latter
discrepancies could reflect incorrect reporting by the case; but
as 31 of the 33 reported breast cancer deaths were confirmed
as cases (although not all died from breast cancer) over-
reporting seems to have been uncommon. Such discrepancies
are thus more likely to be due to deficiencies in cancer
registration or notification rather than over-reporting. A
recent report suggests that only two thirds of incident cancers
are notified through the NHSCR routine follow-up proce-
dure (Villard-Mackintosh et al., 1988). We therefore believe
that our overall results on incidence from all sources, inclu-
ding both traced and untraced relatives in the calculation, are
unlikely to be significantly inflated or reduced.
One potential difficulty in this study is the choice of an
appropriate control group. Comparisons with national mor-
tality rates might be considered inappropriate for two rea-
sons. First, breast cancer rates varied substantially by social
class in the past, which could in principle inflate the observed
risks in relatives of cases. The social class gradient has how-
ever diminished substantially, and by the 1971 census the
SMRs for breast cancer only varied between 117 and 92 for
social class I and V respectively. On the basis of these figures
(and assuming that social class is the same for different
family members) the baseline risk to relatives of a breast
cancer case should be increased by less than 2% to allow for
social class correlation.* Conversely mothers of cases should
have a somewhat lower risk by virtue of the fact that risk is
related to parity (MacMahon et al., 1970). Based on the
figures of MacMahon et al. (1970), this effect should reduce
the risk to the mothers of cases by about 13%. Neither of
these adjustments is substantial in comparison with the
observed familial risks. Moreover, both are irrelevant for the
purpose of counselling relatives.
Results from the parent case-control study suggest that
any bias in our relative risk estimates due to familial aggrega-
tion of other risk factors is likely to be small (UK National
Case-Control Study Group, 1989). Simultaneous adjustment
for ten other factors including age of menarche, age at first
birth, parity, breast feeding, weight and education made a
negligible alteration to the odds ratio associated with family
history (2.41 unadjusted, 2.38 adjusted).
The observed excesses of lung cancer and uterine cancer,
which were particularly marked below age 50, were some-
what surprising. No evidence of an excess of endometrial
cancer in the relatives of breast cancer patients, or vice-versa,
were observed in the Cancer and Steroid Hormone case-
control studies (Schildkraut et al., 1989). Some supporting
evidence for an endometrial cancer excess was found in a
population-based study of cancer mortality in relatives of
breast cancer cases diagnosed under age 40, in which 13
endometrial cancer deaths were observed as against 5.62
expected (Peto, J., Easton, D.F., Matthews, F.E., Swerdlow,
A.J., pers comm). However, this study found little support
for an excess of lung cancer (98 deaths versus 101.74 ex-
pected overall, and 11 deaths versus 8.26 expected under age
50) or of cervical cancer (five deaths against 9.03 overall, and
two against 2.65 below age 50).
Susceptibility to breast and ovarian cancers has recently
been shown, by genetic linkage studies, to be the result of a
predisposing gene on the long arm of chromosome 17 in
some families (Hall et al., 1990; Narod et al., 1991). In these
families the penetrance of the predisposing gene appears to
be high. The current study indicates that, even under age 36,
only a minority of cases (of the order of 10%) could be due
to such highly penetrant genes.
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*In the most extreme case, where relatives always belong to the same
social class, the familial relative risk caused by social class differences
in risk would be given by I:piri'/(I:piri)', where pi is the proportion of
women in social class i and ri is their SMR.
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